BioCentury | Aug 16, 2017
Distillery Therapeutics

Infectious disease

INDICATION: Trypanosome In vitro studies identified a vinyl ketone peptide-based inhibitor of Trypanosoma rhodesain , a cysteine protease from T. brucei rhodesiense , that could help treat African trypanosomiasis. Chemical synthesis and in vitro testing of peptide-based...
BioCentury | Sep 15, 2014
Company News

AbbVie, Besins Healthcare, Teva, U.S. Federal Trade Commission generics, endocrine/metabolic news

...or other restitution. The suit also names Abbott Laboratories (NYSE:ABT, Abbott Park, Ill.) and its Unimed...
BioCentury | May 28, 2009
Distillery Therapeutics

Indication: Infectious disease

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Infectious disease HCV HCV non-structural protein 5B (NS5B) Studies in cell culture identified azaribonucleoside-based inhibitors that could be useful for treating...
BioCentury | Aug 11, 2003
Clinical News

Inhaled dronabinol: Phase I

...Unimed Pharmaceuticals Inc. began a Phase I trial of inhaled dronabinol. Dronabinol is the active ingredient of Unimed's...
BioCentury | Mar 4, 2002
Company News

Inhale, Solvay Pharmaceuticals Inc. deal

...Solvay's Unimed Pharmaceuticals Inc. subsidiary and INHL partnered to develop a metered dose inhaler for dronabinol, a synthetic...
...responsible for developing the formulation and clinical and commercial manufacturing of the formulation and inhaler. Unimed...
...will receive manufacturing revenues, R&D funding, milestones and royalties. Dronabinol is the active ingredient in Unimed's...
BioCentury | Feb 26, 2002
Company News

Inhale in four deals

...PHA), Eyetech (New York, N.Y.) and 3-Dimensional (DDDP), and a pulmonary drug delivery deal with Unimed...
...PEGylation technology to synthesize 3DP 3534, a PEGylated peptide in preclinical testing to treat thrombocytopenia. Unimed...
...a synthetic delta-9-tetrahydrocannabinol, to be used for multiple indications. Dronabinol is the active ingredient in Unimed's...
BioCentury | Sep 4, 2001
Company News

Solvay Pharmaceuticals Inc. management update

...Inc., Marietta, Ga. Business: Cardiovascular, Metabolic Transition: Jean-Louis Anspach to president and CEO of Solvay's Unimed Pharmaceuticals Inc....
BioCentury | Jun 4, 2001
Company News

Solvay Pharmaceuticals Inc., Tap Pharmaceutical sales and marketing update

...Solvay's Unimed Pharmaceuticals Inc. subsidiary and Tap, a joint venture between Abbott Laboratories (ABT, Abbott Park, Ill.) and...
...between Abbott Laboratories (ABT, Abbott Park, Ill.) and Takeda Chemicals Ltd. (Osaka, Japan), will co-promote Unimed's...
BioCentury | Jan 8, 2001
Company News

Unimed, Roxane Laboratories Inc. sales and marketing update

...The companies ended their co-promotion agreement for Unimed's Marinol dronabinol capsules to treat chemotherapy-induced nausea and...
...vomiting and appetite loss or anorexia associated with weight loss in AIDS patients. Going forward, Unimed...
...wholly owned subsidiary of Solvay Pharmaceuticals Inc. (Marietta, Ga.), will manufacture and market the product. Unimed Pharmaceuticals Inc....
BioCentury | Sep 11, 2000
Company News

Axys management update

...Cancer, Autoimmune/Inflammation Hired: David Riggs as SVP and CFO, formerly SVP of business operations at Unimed Pharmaceuticals Inc. WIR...
Items per page:
1 - 10 of 74
BioCentury | Aug 16, 2017
Distillery Therapeutics

Infectious disease

INDICATION: Trypanosome In vitro studies identified a vinyl ketone peptide-based inhibitor of Trypanosoma rhodesain , a cysteine protease from T. brucei rhodesiense , that could help treat African trypanosomiasis. Chemical synthesis and in vitro testing of peptide-based...
BioCentury | Sep 15, 2014
Company News

AbbVie, Besins Healthcare, Teva, U.S. Federal Trade Commission generics, endocrine/metabolic news

...or other restitution. The suit also names Abbott Laboratories (NYSE:ABT, Abbott Park, Ill.) and its Unimed...
BioCentury | May 28, 2009
Distillery Therapeutics

Indication: Infectious disease

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Infectious disease HCV HCV non-structural protein 5B (NS5B) Studies in cell culture identified azaribonucleoside-based inhibitors that could be useful for treating...
BioCentury | Aug 11, 2003
Clinical News

Inhaled dronabinol: Phase I

...Unimed Pharmaceuticals Inc. began a Phase I trial of inhaled dronabinol. Dronabinol is the active ingredient of Unimed's...
BioCentury | Mar 4, 2002
Company News

Inhale, Solvay Pharmaceuticals Inc. deal

...Solvay's Unimed Pharmaceuticals Inc. subsidiary and INHL partnered to develop a metered dose inhaler for dronabinol, a synthetic...
...responsible for developing the formulation and clinical and commercial manufacturing of the formulation and inhaler. Unimed...
...will receive manufacturing revenues, R&D funding, milestones and royalties. Dronabinol is the active ingredient in Unimed's...
BioCentury | Feb 26, 2002
Company News

Inhale in four deals

...PHA), Eyetech (New York, N.Y.) and 3-Dimensional (DDDP), and a pulmonary drug delivery deal with Unimed...
...PEGylation technology to synthesize 3DP 3534, a PEGylated peptide in preclinical testing to treat thrombocytopenia. Unimed...
...a synthetic delta-9-tetrahydrocannabinol, to be used for multiple indications. Dronabinol is the active ingredient in Unimed's...
BioCentury | Sep 4, 2001
Company News

Solvay Pharmaceuticals Inc. management update

...Inc., Marietta, Ga. Business: Cardiovascular, Metabolic Transition: Jean-Louis Anspach to president and CEO of Solvay's Unimed Pharmaceuticals Inc....
BioCentury | Jun 4, 2001
Company News

Solvay Pharmaceuticals Inc., Tap Pharmaceutical sales and marketing update

...Solvay's Unimed Pharmaceuticals Inc. subsidiary and Tap, a joint venture between Abbott Laboratories (ABT, Abbott Park, Ill.) and...
...between Abbott Laboratories (ABT, Abbott Park, Ill.) and Takeda Chemicals Ltd. (Osaka, Japan), will co-promote Unimed's...
BioCentury | Jan 8, 2001
Company News

Unimed, Roxane Laboratories Inc. sales and marketing update

...The companies ended their co-promotion agreement for Unimed's Marinol dronabinol capsules to treat chemotherapy-induced nausea and...
...vomiting and appetite loss or anorexia associated with weight loss in AIDS patients. Going forward, Unimed...
...wholly owned subsidiary of Solvay Pharmaceuticals Inc. (Marietta, Ga.), will manufacture and market the product. Unimed Pharmaceuticals Inc....
BioCentury | Sep 11, 2000
Company News

Axys management update

...Cancer, Autoimmune/Inflammation Hired: David Riggs as SVP and CFO, formerly SVP of business operations at Unimed Pharmaceuticals Inc. WIR...
Items per page:
1 - 10 of 74